scholarly journals PENGARUH VASEKTOMI TERHADAP FUNGSI SEKSUAL PRIA

2013 ◽  
Vol 1 (1) ◽  
Author(s):  
Mir'atul Fitri ◽  
Benny Wantouw ◽  
Lydia Tendean
Keyword(s):  
Sexual Dysfunction ◽  
Elementary Education ◽  
Sexual Function ◽  
Drug Users ◽  
Univariate Analysis ◽  
Target Population ◽  
Cross Sectional ◽  
Male Sexual Function ◽  
Excessive Stress

Abstract: Vasectomy in the community are still poorly understood, such as vasectomy can affect sexual function (sexual dysfunction). The purpose of this study was to determine the effect of vasectomy on male sexual function and the mechanisms of sexual function in men due to vasectomy. This study is a cross sectional analytic survey with a target population of men who have vasectomy totaling 67 people selected by proportional sampling of Manado City BKKBN January to August 2012. Instruments in this study using the questionnaire International Index Erectile Function (IIEF), the analysis of the data in this study using univariate analysis and Mann Whitney Sub Menu 2 Independent simple (SPSS 20 for Windows). The results, the majority of respondents aged > 35 years were 63 people (94.03%), elementary education as many as 48 people (62.34%), earning Rp. 500,000 - Rp. 1.000.000 by 47 people (70.1%), having more than one child as many as 64 people (95.5%), vasectomy contraceptive users with better sexual function by 56 people (83.60%), significant results statistics between vasectomy contraceptive users who have comorbidities, consuming drugs and having stress with sexual function. Contraception has no effect on male sexual function and sexual dysfunction occurs due to men having comorbidities, smoking and excessive alkohol consuming in the long term, drug users, and have excessive stress. Keywords: Vasectomy, Sexual Function, Male.     ABSTRAK: Vasektomi dikalangan masyarakat masih kurang dipahami, seperti vasektomi dapat berdampak terhadap fungsi seksual (disfungsi seksual). Tujuan penelitian ini untuk mengetahui pengaruh vasektomi terhadap fungsi seksual pria dan mekanisme fungsi seksual pada pria akibat vasektomi. Penelitian ini bersifat survei analitik pendekatan cross sectional dengan populasi target pria yang telah divasektomi berjumlah 67 orang dipilih secara proporsional sampling dari data BKKBN Kota Manado Januari-Agustus 2012. Instrumen dalam penelitian ini menggunakan Kuesioner Indeks Fungsi Ereksi Internasional (IIEF), analisa data dalam penelitian ini menggunakan analisa univariat dan analisa Mann Whitney Sub Menu 2 Independent simple (SPSS 20 for Windows). Hasil penelitian didapatkan mayoritas responden usia >35 tahun sebanyak 63 orang (94,03%), berpendidikan SD sebanyak 48  orang (62,34%), berpenghasilan Rp. 500.000 – Rp. 1.000.000 sebanyak 47 orang (70,1%), memiliki anak lebih dari satu orang sebanyak 64 orang (95,5%), pengguna kontrasepsi vasektomi dengan fungsi seksual baik sebanyak 56 orang (83,60%), hasil yang bermakna secara statistik antara pengguna kontrasepsi vasektomi yang memiliki penyakit penyerta, mengkonsumsi narkoba dan mengalami stres dengan fungsi seksual. Kontrasepsi vasektomi tidak berpengaruh pada fungsi seksual pria dan disfungsi seksual terjadi diakibatkan oleh pria memiliki penyakit penyerta, merokok dan mengkonsumsi alhokol dalam jangka waktu panjang dan volume berlebihan, pengguna narkoba, dan memiliki stress berlebihan. Kata kunci: Vasektomi, Fungsi seksual, Pria.

The impact of female sexual dysfunction on male sexual function: A cross sectional study

2017 ◽  
Vol 16 (13) ◽  
pp. e3021
Author(s):  
A. Zachariou ◽  
M. Filiponi ◽  
F. Dimitriadis ◽  
I. Giannakis ◽  
P. Lantin ◽  
...  
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Function ◽  
Female Sexual Dysfunction ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Male Sexual Function ◽  
The Impact

Factors Associated Sexual Dysfunction in Patients Pelvic Organ Prolapse at Dr. Cipto Mangunkusumo and Fatmawati Hospital Jakarta in 2016

2018 ◽  
Vol 24 (8) ◽  
pp. 6147-6150
Author(s):  
Suskhan Djusad ◽  
Surahman Hakim ◽  
Tyas Priyatini ◽  
Fernandi Moegni ◽  
Shirley Anggraeni ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Pelvic Organ Prolapse ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Univariate Analysis ◽  
Significant Risk ◽  
Pelvic Organ ◽  
Bivariate Analysis ◽  
Cross Sectional ◽  
Factors Associated

Pelvic Organ Prolapse (POP) is a bulge or protrusion of pelvic organs and related segments into or through the vagina. Disturbances in sexual function rarely complained, but from the literature it is known that patients with stage 3–4 prolapse associated with difficulty in achieving an orgasm. This study aims to determine the prevalence of sexual dysfunction in patients with POP and factors associated with sexual dysfunction among them. A cross-sectional design was conducted in Dr. Cipto Mangunkusumo and Fatmawati Hospital Jakarta. All patients who met the inclusion criteria of POP filled out a questionnaire of sexual function index (FSFI-19), then performed univariate analysis of data on the characteristics of the data subject, and bivariate and multivariate analysis to know the relationship between the dependent and independent variables. Of the 82 data, the prevalence of sexual dysfunction in patients with POP reached 57.3%. While most of the patients had experienced menopause POP also with a prevalence of 76.8%. The prevalence of sexual dysfunction in patients who were menopausal POP by 66.7%. From the results of the bivariate analysis, age, menopause, obesity and stage of prolapse were a significant risk factor on the incidence of sexual dysfunction in patients with POP. The variables of age, smoking, menopause, obesity and stage of prolapse, p < 0.25 to be included in the multivariate analysis. From the multivariate analysis, the variables associated with the incidence of sexual dysfunction in patients with POP were age >60 by OR 8 (IK95 2,45–26.12), and obesity (BMI 30 kg/m2) with an OR of 0.30 (CI 95 0.09 to 0.98). Advanced age and obesity are associated with the incidence of sexual dysfunction in patients with POP.

scholarly journals Gender Differences in Depression and Sex Hormones among Patients Receiving Long-Term Opioid Treatment for Chronic Noncancer Pain in Taiwan—A Multicenter Cross-Sectional Study

2021 ◽  
Vol 18 (15) ◽  
pp. 7837
Author(s):  
Shung-Tai Ho ◽  
Tso-Chou Lin ◽  
Chun-Chang Yeh ◽  
Kuang-I Cheng ◽  
Wei-Zen Sun ◽  
...  
Keyword(s):  
Sexual Function ◽  
Sex Hormones ◽  
Sex Hormone ◽  
Cross Sectional ◽  
Chronic Noncancer Pain ◽  
Depression Diagnosis ◽  
Opioid Treatment ◽  
Hormone Levels ◽  
Noncancer Pain

Background: Long-term use of opioids for chronic noncancer pain is associated with sex hormone disturbances. The interferences with sex hormones, sexual function, and depression were investigated in patients with chronic noncancer pain. Methods: A cross-sectional multicenter survey was conducted on 170 officially registered outpatients receiving long-term opioid treatment in nine medical centers in Taiwan between October 2018 and July 2019. Serum sex hormone levels were examined after the collection of self-administered questionnaires containing the Taiwanese version of the Brief Pain Inventory, depressive status, and sexual function interference. Results: Among 117 (68.8%) questionnaire responses from 170 enrolled outpatients, 38 women and 62 men completed the sex hormone tests, among whom only 23 (23%) had previously received blood hormone tests. Low serum total testosterone levels were detected in 34 (89.5%) women (<30 ng/dL) and 31 (50%) men (<300 ng/dL). Over 60% of women and men reported reduced sexual desire and function despite a nearly 50% reduction in pain intensity and daily function interference over the previous week after opioid treatment. Women generally had higher risks of a depression diagnosis (p = 0.034) and severe depressive symptoms (p = 0.003) and nonsignificantly lower opioid treatment duration (median 81 vs. 120 months) and morphine milligram equivalent (median 134 vs. 165 mg/day) compared with men. Conclusions: This survey demonstrated the high prevalence of depression diagnosis, low sex hormone levels, and reduced sexual function among Taiwanese patients with chronic noncancer pain receiving prolonged opioid therapy. Regular hypogonadal screenings are recommended for further management.

scholarly journals FRI0650-HPR SEXUAL DYSFUNCTION IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 929.2-929
Author(s):  
G. V. Espasa ◽  
L. Gonzalez Lucero ◽  
Y. Soria Curi ◽  
A. L. Barbaglia ◽  
S. M. Mazza ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Lupus Erythematosus ◽  
Severe Depression ◽  
Systemic Lupus ◽  
Depression Anxiety Stress Scale ◽  
Cross Sectional ◽  
Healthy Group ◽  
Healthy Women

Background:Sexual dysfunction is the alteration in one or several phases of sexual activity (desire, excitement, plateau, orgasm and resolution), which can culminate in frustration, pain and a decrease in the frequency of sexual intercourse. There are few studies that associate sexual dysfunction with Systemic Lupus Erythematosus (SLE) due to the difficulty in assessing it and its multifactorial cause.Objectives:Determine the frequency of sexual dysfunction and analyze associated factors in patients with SLE.Methods:A descriptive cross-sectional study was conducted. We included patients who attended the Rheumatology unit between May and July 2019; over 18 years of age, with a diagnosis of SLE according to the ACR 1997 and / or SLICC 2012 criteria, and healthy patients matched by age as control. Demographic and disease-related variables were studied. The DASS-21 (Depression Anxiety Stress Scale) scale that evaluates depression, anxiety and stress, and the Female Sexual Function Index (FSFI) that assesses 6 domains (desire, excitement, lubrication, orgasms, satisfaction and pain) were applied with a cut-off point ≤ 26.5 to define sexual dysfunction. Women over 50 years old, with secondary Sjogren’s syndrome, menopause, severe depression and illiterate patients were excluded.Results:One hundred and twenty three women were included (60 with SLE and 63 controls), with a mean age of 34.3 ± 8.3 and 31.7 ± 4.4 years respectively. The prevalence of sexual dysfunction in the SLE group was 71.7%; 95% CI = [58.5 – 82.5], and 23.8%, 95% CI = [13.9 – 36.2] in healthy patients. There were significant differences in all domains of sexual function between women with SLE and healthy group. In the desire, excitement and pain domains the differences were notable. The total FSFI score in patients with SLE was 18.2 ± 11.2 and in healthy women 28.3 ± 6.9 (p=0.001). Stress, anxiety and depression were observed in 58.4%, 58.3% and 50% of women with SLE and 19%, 20.6% and 28.5% of healthy women respectively (p=0.001). No association was found between sexual dysfunction and age, age at diagnosis, disease activity or treatment (pNS). No association was found in patients with SLE when analyzing the effect of sexual dysfunction in stress, depression and anxiety variables, in opposition to the healthy group (p<0.05).Conclusion:The prevalence of sexual dysfunction in patients with SLE was high (71.7%). Depression, Anxiety, and Stress were not decisive variables in Sexual Dysfunction.Disclosure of Interests:None declared

Long-term sexual function in survivors of vulvar cancer: A cross-sectional study

2012 ◽  
Vol 126 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Menke H. Hazewinkel ◽  
Ellen T.M. Laan ◽  
Mirjam A.G. Sprangers ◽  
Guus Fons ◽  
Matthé P.M. Burger ◽  
...  
Keyword(s):  
Sexual Function ◽  
Vulvar Cancer ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional

scholarly journals Sexuality in Ageing Male: Review of Pathophysiology and Treatment Strategies for Various Male Sexual Dysfunctions

2019 ◽  
Vol 7 (10) ◽  
pp. 98 ◽  
Author(s):  
Chung
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Function ◽  
Treatment Strategies ◽  
The Elderly ◽  
Older Men ◽  
Current Treatment ◽  
Poor Treatment ◽  
Ageing Male ◽  
Male Sexual Function ◽  
Normal Ageing

Sexual function among older men is often thought to decrease as part of normal ageing biology despite the fact that sexuality remains an important issue in the elderly. Sexual dysfunction in the aged male is likely multifactorial in nature, with the development and/or progression of medical comorbidities often resulting in decline in male sexual function and poor treatment response. At present, sexual dysfunction in the ageing male is poorly investigated and understood, and current treatment strategies aim at improving sexual desire and erectile function with limited data on ejaculatory and orgasmic dysfunctions. In addition, men are often reticent to seek help for health concerns including sexual dysfunction. The following article provides a narrative review of strategies to address various aspects of sexual dysfunction in the ageing male. Clinicians need to be educated to be sensitive when discussing sexuality issues among older men and to present practical solutions that take into account individual and cultural differences.

scholarly journals Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment

2019 ◽  
Vol 8 (3) ◽  
pp. 321 ◽  
Author(s):  
Carlos Llanes ◽  
Ana Álvarez ◽  
M. Pastor ◽  
M. Garzón ◽  
Nerea González-García ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Sexual Dysfunction ◽  
Methadone Maintenance Treatment ◽  
Maintenance Treatment ◽  
Methadone Maintenance ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Clinical Interviews

This study examined whether methadone (hereinafter referred to as MTD) maintenance treatment (MMT) is correlated with sexual dysfunction (SD) in heroin-dependent men. This was conducted to determine the prevalence of sexual dysfunction and if there is a relationship between duration and dose among men on MMT and its impact on the quality of life. The study combined a retrospective and a cross-sectional survey based on the Kinsey Scale, TECVASP, and PRSexDQ-SALSEX clinical interviews of 85 patients who are currently engaged in MMT. Sexual dysfunction in all five PRSexDQ-SALSEX domains (lack of libido, delay in orgasm, inability to orgasm, erectile dysfunction, and tolerance or acceptance of changes in sexual function) was associated with dose and long-term use of heroin. All dimensions of SD were affected by the MTD intake. From the analysis of our sample, we may conclude that dose of MTD and overall score of SD were directly associated. However, no evidence was found to prove that treatment duration and severity of SD were linked. It is notable that only one tenth of the patients spontaneously reported their symptoms of the sexual sphere, but up to a third considered leaving the MMT for this reason.

Sign in / Sign up

Export Citation Format

Share Document